Weijie Lin, MD
Cornea and External Diseases Specialist · Milford, CTNPI 1801356092
Payments from drug & device makers
Across 26 payments — averaging $380.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$9K
- Alcon$406
- Dompe US, Inc.$395
- Tarsus Pharmaceuticals, Inc.$393
- Biotissue Holdings Inc.$135
- Bausch & Lomb Americas Inc.$41
- plus $31 from 1 others
What the payments were for
- Consulting fees$8,25083%
- Food & beverage$1,65217%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 4 | $8,501 |
| Alcon | 3 | $406 |
| Dompe US, Inc. | 7 | $395 |
| Tarsus Pharmaceuticals, Inc. | 8 | $393 |
| Biotissue Holdings Inc. | 1 | $135 |
| Bausch & Lomb Americas Inc. | 2 | $41 |
| Oyster Point Pharma, Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CE-marked KXLA system$5,500
- KXL System$2,750
- Clareon$285
- XDEMVY$245
- Oxervate$230
- iDoseTR$204
- TRYPTYR$120
How this compares
Too few cornea and external diseases specialist providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 15 | $4,756 |
| Brimonidine Tartrate | 14 | $1,269 |
| Prednisolone Acetate | 14 | $594 |
| Latanoprost | 27 | $299 |
| ErythromycinErythromycin Base | 23 | $244 |
| Dorzolamide Hcl | 11 | $192 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $165 |
Paid to pharmacies, not to this prescriber.
Other cornea and external diseases specialist in Milford
- Yvonne WangNew Haven$2K
- Archna JoharProspect$2K
- Anisha JangiDanbury$2K
- Joel GeffinWaterbury$896
- Stephen ZuckermanDanbury$839
- Jessica ChenNew Haven$717
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.